Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-20 4:53 pm Sale | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 2,170,000 8.58% | -215,000 (-9.01%) | View |
| 2022-01-28 4:05 pm Sale | 13D | Eton Pharmaceuticals, Inc. ETON | HARROW HEALTH INC. HROW | 1,982,000 8.1% | -1,518,000 (-43.37%) | View |
| 2022-01-24 4:05 pm Sale | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 2,385,000 9.69% | -1,307,700 (-35.41%) | View |
| 2021-06-17 4:40 pm Purchase | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 3,692,700 15.07% | 1,067,700 (+40.67%) | View |
| 2021-02-16 5:02 pm Sale | 13G | Eton Pharmaceuticals, Inc. ETON | APPEL PETER A | 1,084,329 4.48% | -165,000 (-13.21%) | View |
| 2020-04-06 7:20 pm Purchase | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 3,640,000 17.77% | 1,300,000 (+55.56%) | View |
| 2020-02-14 4:30 pm Purchase | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 1,469,456 8.25% | 587,778 (+66.67%) | View |
| 2020-02-04 4:51 pm Purchase | 13G | Eton Pharmaceuticals, Inc. ETON | BRYNJELSEN SEAN | 1,374,940 7.6% | 215,000 (+18.54%) | View |
| 2019-05-24 5:20 pm Sale | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 881,678 5% | -840,322 (-48.80%) | View |
| 2019-02-11 4:58 pm Purchase | 13G | Eton Pharmaceuticals, Inc. ETON | BRYNJELSEN SEAN | 1,159,940 6.6% | 1,159,940 (New Position) | View |
| 2018-11-23 06:15 am Purchase | 13D | Eton Pharmaceuticals, Inc. ETON | HARROW HEALTH INC. HROW | 3,500,000 20.7% | 3,500,000 (New Position) | View |
| 2018-11-21 5:24 pm Purchase | 13G | Eton Pharmaceuticals, Inc. ETON | APPEL PETER A | 1,249,329 7.4% | 1,249,329 (New Position) | View |